Microchemical Journal, Год журнала: 2024, Номер unknown, С. 112589 - 112589
Опубликована: Дек. 1, 2024
Язык: Английский
Microchemical Journal, Год журнала: 2024, Номер unknown, С. 112589 - 112589
Опубликована: Дек. 1, 2024
Язык: Английский
Materials Science and Engineering B, Год журнала: 2025, Номер 314, С. 118057 - 118057
Опубликована: Фев. 6, 2025
Язык: Английский
Процитировано
1Bioelectrochemistry, Год журнала: 2024, Номер 161, С. 108847 - 108847
Опубликована: Ноя. 15, 2024
Язык: Английский
Процитировано
4ACS Synthetic Biology, Год журнала: 2025, Номер 14(1), С. 21 - 40
Опубликована: Янв. 6, 2025
The field of healthcare diagnostics is navigating complex challenges driven by evolving patient demographics and the rapid advancement new technologies worldwide. In response to these challenges, biosensors offer distinctive advantages over traditional diagnostic methods, such as cost-effectiveness, enhanced specificity, adaptability, making their integration with point-of-care (POC) platforms more feasible. recent years, aptasensors have significantly evolved in capabilities through emerging microfluidics, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems, wearable devices, machine learning (ML), driving progress precision medicine global solutions. Moreover, advancements not only improve accuracy but also hold potential revolutionize early detection, reduce costs, outcomes, especially resource-limited settings. This Account examines key advancements, focusing on how scientific breakthroughs, including artificial intelligence (AI), improved sensitivity precision. Additionally, has enabled real-time monitoring data analysis, fostering advances personalized healthcare. Furthermore, commercialization aptasensor could increase availability clinical settings support use widespread solutions for health challenges. Hence, this review discusses technological improvements, practical uses, prospects while surrounding standardization, validation, interdisciplinary collaboration application. Finally, ongoing efforts address are ensure that can be effectively implemented diverse systems.
Язык: Английский
Процитировано
0Materials Science and Engineering B, Год журнала: 2025, Номер 314, С. 118073 - 118073
Опубликована: Фев. 3, 2025
Язык: Английский
Процитировано
0Biosensors, Год журнала: 2025, Номер 15(2), С. 80 - 80
Опубликована: Янв. 31, 2025
Detecting multiple tumor markers is of great importance. It helps in early cancer detection, accurate diagnosis, and monitoring treatment. In this work, gold nanoparticles–toluidine blue–graphene oxide (AuNPs-TB–GO) nanoparticles–carboxyl ferrocene–tungsten disulfide (AuNPs–FMC–WS2) nanocomposites were prepared for labeling Carcinoembryonic antigen (CEA) antibody Carbohydrate 72–4 (CA72-4) antibody, respectively, used as two kinds probes with different electrochemical signals. With the excellent magnetic performance biotin immune beads (IMBs), biofunctional IMBs firmly deposited on glassy carbon electrode (MGCE) surface by applying a constant field, then CEA CA72-4 immobilized avidin–biotin conjugation. The assay was based change detection peak current. Under optimum experimental conditions, linear range two-component immunosensor from 0.01 to 120 ng/mL, low limit 0.003 0.05 35 U/mL, 0.016 U/mL. results showed that proposed enabled simultaneous exhibited good reproducibility, high selectivity, sensitivity. particular, multiplexed immunoassay approach does not require sophisticated fabrication well-suited high-throughput biosensing application other areas.
Язык: Английский
Процитировано
0Surfaces and Interfaces, Год журнала: 2025, Номер unknown, С. 106047 - 106047
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Materials, Год журнала: 2025, Номер 18(5), С. 1014 - 1014
Опубликована: Фев. 25, 2025
A hydrothermal and combustion-reduction process with polyvinyl pyrrolidone (PVP) as a restricted growth agent galactose reducing was developed for the fabrication of rod-like α-Fe2O3/Fe3O4 magnetic nanocomposites (MNCs). Firstly, β-FeOOH nanorods (NRs) were fabricated by method, PVP agent. To obtain smaller size better applications in biomedical field, concentrations FeCl3 PVP, temperature, time optimized 0.171 M, 0.163 mM, 100 °C, 8 h, NRs 193.1 nm average length 43.2 diameter. Then, precursors, MNCs prepared via agent; factors calcination temperature mass ratio assessed 300 0.5 1:2, respectively. The under conditions 81.6 23.9 diameter, while their saturation magnetization reached 69.8 emu/g.
Язык: Английский
Процитировано
0Ceramics International, Год журнала: 2024, Номер unknown
Опубликована: Сен. 1, 2024
Язык: Английский
Процитировано
3Colloids and Surfaces B Biointerfaces, Год журнала: 2024, Номер 239, С. 113963 - 113963
Опубликована: Май 13, 2024
Язык: Английский
Процитировано
2Microchemical Journal, Год журнала: 2024, Номер unknown, С. 112589 - 112589
Опубликована: Дек. 1, 2024
Язык: Английский
Процитировано
0